Skip to main content

Indaptus Therapeutics, Inc.

INDP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001857044

No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q3 2026, worth $2.18M in total; no superinvestor holds it.

Holders of 5% or more of INDP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Indaptus Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of INDP
HolderLatest formStakeChangeFirst filedLatest filingFiling
Lazar David E.13D/A47.93%2.06M shares−50.07 ppfrom 98.00%Mar 2, 20262 filingsMar 24, 2026SEC
Yao Yun13D/A27.34%42.0M shares−4.17 ppfrom 31.51%Mar 30, 20264 filingsOct 22, 2026SEC
Sino Lion Ventures Ltd13D/A25.32%38.9M shares−3.87 ppfrom 29.19%Jun 26, 20262 filingsOct 22, 2026SEC
Meckler Jeffrey A13D/A12.70%273.1K shares–Oct 10, 20243 filingsDec 30, 2025SEC
Dai Junyi13D/A7.33%11.3M shares−1.11 ppfrom 8.44%Jun 26, 20262 filingsOct 22, 2026SEC
Yang Ting13D/A6.48%9.95M shares−1.96 ppfrom 8.44%Jun 26, 20262 filingsOct 21, 2026SEC
Newman Michael James13D/A5.40%115.6K shares–Aug 13, 20213 filingsDec 30, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

28 Schedule 13D and 13G filings on Indaptus Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on INDP
Filed (ET)FilerFormStakeChangeEvent dateFiling
Oct 22, 20264:06 PM ETSino Lion Ventures Ltdand 1 other13D/A25.32%38.9M shares−3.87 ppfrom 29.19%Oct 16, 2026SEC
Oct 22, 20264:05 PM ETDai Junyi13D/A7.33%11.3M shares−1.11 ppfrom 8.44%Oct 16, 2026SEC
Oct 22, 20264:05 PM ETYao Yun13D/A27.34%42.0M shares−4.17 ppfrom 31.51%Oct 16, 2026SEC
Oct 21, 20264:05 PM ETYang Ting13D/A6.48%9.95M shares−1.96 ppfrom 8.44%Oct 16, 2026SEC
Jun 26, 20269:40 PM ETSino Lion Ventures Ltdand 1 other13D/A29.19%38.9M shares–Jun 24, 2026SEC
Jun 26, 20268:00 PM ETDai Junyi13D/A8.44%11.3M shares–Jun 24, 2026SEC
Jun 26, 20268:00 PM ETYang Ting13D/A8.44%11.3M shares–Jun 24, 2026SEC
Jun 26, 20268:00 PM ETYao Yun13D/A31.51%42.0M shares−5.59 ppfrom 37.10%Jun 24, 2026SEC
Apr 29, 20264:05 PM ETYao Yunand 5 others13D/A37.10%42.0M shares−0.70 ppfrom 37.80%Apr 28, 2026SEC
Apr 6, 20264:40 PM ETYA II PN, Ltd.and 7 others13G/A0.00%0 shares−9.99 ppfrom 9.99%Below 5%Dec 31, 2025SEC
Mar 30, 20269:46 PM ETYao Yunand 5 others13D37.80%42.0M sharesNewMar 23, 2026SEC
Mar 24, 20264:05 PM ETLazar David E.13D/A47.93%2.06M shares−50.07 ppfrom 98.00%Mar 23, 2026SEC
Mar 2, 20265:20 PM ETLazar David E.13D98.00%111.0M sharesNewFeb 26, 2026SEC
Dec 30, 20254:01 PM ETMeckler Jeffrey A13D/A12.70%273.1K shares–Dec 22, 2025SEC
Dec 30, 20254:01 PM ETNewman Michael James13D/A5.40%115.6K shares–Dec 22, 2025SEC
Feb 18, 20254:03 PM ETYA II PN, Ltd.and 7 others13G9.99%1.41M sharesNewFeb 13, 2025SEC
Nov 26, 2024Meckler Jeffrey A13D/AOld format–––SEC
Oct 10, 2024Meckler Jeffrey A13DOld format–New–SEC
Aug 17, 2023Anderson Glen R.13G/AOld format–––SEC
Jul 8, 2022Anderson Glen R.13G/AOld format–––SEC
Feb 11, 2022Intracoastal Capital, LLC13G/AOld format–––SEC
Nov 17, 2021Anderson Glen R.13D/AOld format–––SEC
Oct 26, 2021Newman Michael James13D/AOld format–––SEC
Oct 26, 2021Lee Hoonmo13D/AOld format–––SEC
Oct 26, 2021Anderson Glen R.13D/AOld format–––SEC
Aug 19, 2021Anderson Glen R.13DOld format–New–SEC
Aug 13, 2021Lee Hoonmo13DOld format–New–SEC
Aug 13, 2021Newman Michael James13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Indaptus Therapeutics, Inc. shares.

No Form 144 notices for Indaptus Therapeutics, Inc. are on file.